Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Hollingsworth, Michael A.	University Of Nebraska Medical Center United States	Pancreatic Cancer Detection Consortium	5U01CA210240-09	Matthew Young, Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	4U01CA288375-03	Sidney Fu, M.D.
Huang, Yijian	Emory University United States	Analytic diagnosis methods for disease ruling	5R01CA283687-02	Guillermo Marquez, Ph.D.
Huang, Ying	Fred Hutchinson Cancer Center United States	Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies	5R01CA277133-04	Matthew Young, Ph.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-05	Matthew Young, Ph.D.
Iyer, Prasad G.	Mayo Clinic Arizona United States	Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma	2R01CA241164-07	Matthew Young, Ph.D.
Jiang, Feng	Biotarget Dx Llc United States	Plasma microRNA biomarkers for lung cancer diagnosis	7UH3CA251139-05	Guillermo Marquez, Ph.D.
Justilien, Verline	Mayo Clinic Jacksonville United States	ECT2 Isoform Switch in Pancreatic Cancer.	5R21CA296671-02	Matthew Young, Ph.D.
Kanwal, Fasiha	Baylor College Of Medicine United States	Risk Stratification for and Early Detection of Liver Cancer	5U01CA230997-08	Sidney Fu, M.D.
Kibel, Adam S	Brigham And Women'S Hospital United States	Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer	5U01CA268810-03	Guillermo Marquez, Ph.D.
Kirkwood, Kimberly Saunders	University Of California, San Francisco United States	Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer	5U01CA282269-02	Matthew Young, Ph.D.
Kisiel, John	Mayo Clinic Rochester United States	Multi-cancer Early Detection	2R01CA214679-08	Matthew Young, Ph.D.
Klein, Alison P	Johns Hopkins University United States	Improving Management of patients at High Risk of Pancreatic Cancer	5R01CA299421-02	Matthew Young, Ph.D.
Kuhn, Peter	University Of Southern California United States	Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma	4U01CA285013-03	Nicholas Hodges, Ph.D.
Labaer, Joshua	Arizona State University-Tempe Campus United States	High-throughput immunoproteomics for cancer biomarker discovery	5U2CCA271903-04	Christos Patriotis, Ph.D., M.Sc.